Tag Archives: Edward White

Aileron Therapeutics (ALRN) Receives a Rating Update from a Top Analyst

H.C. Wainwright analyst Edward White maintained a Buy rating on Aileron Therapeutics (ALRN – Research Report) today and set a price target of $2.00. The company’s shares closed last Monday at $1.14. According to TipRanks.com, White is a top 100

Dynavax (DVAX) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Edward White maintained a Buy rating on Dynavax (DVAX – Research Report) today and set a price target of $12.00. The company’s shares closed last Thursday at $6.13. According to TipRanks.com, White is a top 100 analyst

IDEAYA Biosciences (IDYA) Receives a Rating Update from a Top Analyst

H.C. Wainwright analyst Edward White maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) today and set a price target of $13.00. The company’s shares closed last Friday at $8.04. According to TipRanks.com, White is a top 100

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (NASDAQ: TGTX) and Allogene Therapeutics (NASDAQ: ALLO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TG Therapeutics (TGTX – Research Report) and Allogene Therapeutics (ALLO – Research Report) with bullish sentiments. TG Therapeutics (TGTX) H.C. Wainwright analyst

H.C. Wainwright Sticks to Their Buy Rating for Karyopharm Therapeutics (KPTI)

H.C. Wainwright analyst Edward White reiterated a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) on May 20 and set a price target of $40.00. The company’s shares closed last Friday at $20.65. According to TipRanks.com, White is a

Why Did H.C. Wainwright Downgrade Syndax Pharmaceuticals’ Stock?

Syndax Pharmaceuticals (SNDX – Research Report) received a Hold rating and a $15.00 price target from H.C. Wainwright analyst Edward White today. The company’s shares closed last Friday at $15.62. According to TipRanks.com, White is a top 100 analyst with